baber/WOPTO huggingface dataset:
Patent NZ-578771-A (NZ)
Title: Sustained release capsules with overcap rupturable first to allow dose dump before further dose delivered by spring biased piston
Inventor: HOLMES ROBERT WILLIAM LACHLAN
IPC: A61D7/00
Filed: 2010-06-10
Abstract: An intraruminal sustained release capsule is capable of delivering a sustained release dose of a first medicament to an animal, as well as either or both of a dump dose of a second medicament or mineral, and an exit dose of a third medicament or mineral. The capsule can have a dissolvable overcap moulded from plasticised starch enabling a dump dose of medicament to be held between the overcap and one end of the capsule. A piston within the body of the capsule can be modified to enable it to accommodate an exit dose of medicament within its hollow interior which is aligned with an aperture at the end of the capsule which enables release of the medicaments to the rumen. After insertion of the capsule in the animal the overcap (if present) dissolves and separates from the capsule to release the dump dose of medicament. The sustained release medicament is then dispensed via the apertured end, followed by the release of the exit dose of medicament (if present).
Patent NZ-579273-A (NZ)
Title: Methods of treating ophthalmic diseases involving an inhibitor of beta-amyloid
Inventor: LIN CHIA-YANG
IPC: C07K16/18
Filed: 2008-03-06
Abstract: Disclosed are methods of using inhibitors (including monoclonal antibodies) directed against amyloid-beta peptide for the treatment of ophthalmic diseases such as age-related macular degeneration.
Patent NZ-579626-A (NZ)
Title: Crystalline minocycline base and processes for its preparation
Inventor: MENDES ZITA
IPC: C07C237/26
Filed: 2008-02-22
Abstract: The disclosure relates to crystalline minocycline base. In particular, three crystalline polymorphic forms, designated Form I, Form Il and Form III, of minocycline base characterised by XRD and IR data are disclosed. Processes for preparing these polymorphic forms are also disclosed. For example, Form I is prepared by dissolving and/or suspending amorphous minocycline base in an organic solvent chosen from ethers followed by crystallisation from the mixture.
Patent NZ-581396-A (NZ)
Title: Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenic human idiotype antibodies
Inventor: BUELOW RONALD
IPC: A01K67/027
Filed: 2008-05-30
Abstract: Provided is a method for producing a non-human viable germ cell having at least one inactivated endogenous immunoglobulin (Ig) locus, comprising expressing at least one meganuclease in a germ cell, fertilized oocyte or embryo, to generate a viable germ cell having at least one inactivated endogenous Ig locus wherein said meganuclease recognizes a meganuclease target sequence present in or proximal to said endogenous Ig locus. Transgenic animals produced by the method are useful in the production of monoclonal antibodies.
Patent NZ-581859-A (NZ)
Title: Anthelmintic combination comprising 2-desoxoparaherquamide and abamectin
Inventor: GEARY TIMOTHY G
IPC: A61K31/365
Filed: 2008-06-16
Abstract: Disclosed is a composition comprising 2-desoxoparaherquamide and abamectin. The composition is used to treat parasitic infestations in mammals and to reduce the frequency of anthelmintic resistance genes in populations of trichostrongyloid nematodes.
Patent NZ-582917-A (NZ)
Title: Nmda receptor antagonists for neuroprotection
Inventor: LIOTTA DENNIS C
IPC: A61K31/497
Filed: 2008-06-30
Abstract: 582917 Disclosed are compounds of Formula I, salts or esters thereof, and methods for their preparation. Specific examples of compounds of Formula I include: N-(4-{ 3-[4-(3,4-Difluoro-phenyl)-piperazin-1-yl]-2-(S)-hydroxypropoxy} -phenyl)- methanesulfonamide, 6-{ 3-14-(4-Chloro-phenyl)-piperazin-1-yl]-2-(S)-hydroxy-propoxyl} -3H-benzooxazol-2-one, (4-{ 3-[4-(3,4-Difluoro-phenyl)-piperazin-1-yl]-propoxy} -phenyl)-urea, and N-[2-(3,4-Dichloro-phenylamino)-ethyl]-3-(4-methanesulfonylamino-phenyl)-propionamide. Compounds of Formula I are NMDA receptor antagonists / blockers and are useful for treating or preventing neuropathic pain, stroke, traumatic brain injury, epilepsy and neurological events or neurodegeneration resulting from NMDA receptor activation.
Patent NZ-584354-A (NZ)
Title: Sheave block having removable side plate and post
Inventor: LANGE KENNETH
IPC: B63B21/04
Filed: 2008-09-15
Abstract: A block (10) with a rotating sheave (12) mounted between a pair of side plates (14a, 14b). Captured between the side plates is a post (18) about which a mounting loop may be mounted. The post is removable from the between the side plates to permit the loop to be attached or detached from the block.
Patent NZ-588718-A (NZ)
Title: Indoor temperature and humidity regulation system using far infrared radiation
Inventor: FUTAEDA TAKAHARU
IPC: F24F5/00
Filed: 2009-04-22
Abstract: Disclosed is an indoor environment regulating system with improved energy efficiency. The system is provided with an indoor surface structural member constructed of a material comprising a far-infrared emitting substance that emits and absorbs far-infrared rays and has a far-infrared emissivity of 0.6 or greater, and a cooling and/or heating source having a cooling and/or heating surface constructed of a material comprising the same far-infrared emitting substance as the far-infrared emitting substance of the indoor surface structural member. The far-infrared emitting substance of the cooling and/or heating surface resonates with the far-infrared emitting substance of the indoor surface structural member via far-infrared rays, and wherein the cooling and/or heating surface is exposed to an indoor space. When the cooling surface is cooled by the cooling source, the cooling surface becomes a primary cold radiation source during the cooling, and the far-infrared emitting substance of the cooling surface absorbs, via resonance, the far-infrared rays emitted by the far-infrared emitting substance of the indoor surface structural member. The indoor surface structural member is rendered a secondary cold radiation source to a human body and/or indoor environment, and/or when the heating surface is heated by the heating source. The heating surface becomes a primary thermal radiation source during the heating, and the far infrared rays emitted by the far-infrared emitting substance of the heating surface are absorbed, via resonance, by the far-infrared emitting substance of the indoor surface structural member. The indoor surface structural member is rendered a secondary thermal radiation source to a human body and/or indoor environment.
Patent NZ-591355-A (NZ)
Title: Low-tack adhesives having enhanced bonds with polymeric substrates for reclosable fastener and packages
Inventor: KINIGAKIS PANAGIOTIS
IPC: B31B50/62
Filed: 2011-02-24
Abstract: Disclosed herein is a polymeric base with an adhered UV-cured adhesive applied thereto comprising: a polymeric substrate having an amount of adhesion promoter filler particles dispersed throughout at least a portion thereof wherein the adhesion promoter filler particles are selected from the group consisting of clay, phyllosilicates, calcium carbonate, montmorillonite, dolomite, talc, mica, and mixtures thereof;a low tack UV-cured adhesive including 1 to 90 percent of a UV-curable acrylic oligomer where the UV-curable acrylic oligomer is an acrylic acid ester, 1 to 65 percent of a tack control component where the tack control component is an aliphatic urethane acrylate oligomer, and optionally 5 to 20 percent of at least one elastomeric material where the elastomeric material includes one of curable elastomeric acrylate esters or methacrylate esters selected from the group consisting of polybutadiene, saturated polybutadiene and polyurethane, the low tack UV-cured adhesive having a tack value exhibiting a rolling ball tack of about 4 to about 14 inches as measured using modified test method ASTM D3121 where the modified test uses a glass ball having a diameter of about 1/8 inch and a release point about two inches up the incline, the low tack UV-cured adhesive applied to the polymeric substrate having the adhesion promoter filler particles dispersed throughout at least a portion thereof; and at least a portion of the adhesion promoter filler particles positioned at an interface of the polymeric substrate and the low tack UV-cured adhesive effective to form a bond strength of the low tack UV-cured adhesive to the polymeric substrate of at least about 600 grams per linear inch.
Patent NZ-592345-A (NZ)
Title: Clean-in-place shaft bushing
Inventor: ISENBERG TIMOTHY J
IPC: F16C17/24
Filed: 2011-04-19
Abstract: A shaft bushing is provided that can be automatically cleaned in place, without requiring manual cleaning by a technician, and that can be used with food processing equipment. The shaft bushing has a body with a circumferential sidewall, opposing ends, and an opening in at least one of the ends the can accept cleaning fluid thereinto. The opening may be defined by ends of longitudinal grooves that extend along the bushing and that may direct the cleaning fluid between the bushing body and the support structure, and/or the bushing body and the shaft.
Patent NZ-594423-A (NZ)
Title: Wear resistant slurry pipe fitting
Inventor: DOIG SCOTT
IPC: B65G53/52
Filed: 2010-01-20
Abstract: 594423 A wear resistant pipe fitting having an inlet end 12 in fluid communication, in use, with a first linear pipe segment 16, and an outlet end 14 in fluid communication, in use, with a second linear pipe segment 18, the pipe fitting comprising a first eccentric reducer 22 arranged to receive a slurry or pipeline fluid from the first linear pipe section 16 and deliver the slurry or pipeline fluid to a second eccentric reducer 26. The first eccentric reducer 22 has an increasing cross-sectional area in the direction of fluid flow. The second eccentric reducer 26 is arranged to receive the slurry or fluid from the first eccentric reducer 22 and deliver the slurry or pipeline fluid to the second linear pipe section 18. The second eccentric reducer 26 has a decreasing cross-sectional area in the direction of fluid flow. A flow interrupter device 40 in a form of an elongate probe or rod is positioned within the first eccentric reducer 22 for disrupting the flow of the slurry or pipeline fluid before the slurry or fluid enters the second eccentric reducer 26. The flow interrupter device 40 has a first end terminating in a leading edge and in use, the leading edge is the portion of the flow interrupter device 40 which the slurry or pipeline fluid encounters first as it travels through the pipe fitting.
Patent NZ-594903-A (NZ)
Title: A device including an actuation system comprising a dose chamber, a working chamber, an annular wall and a valve mechanism
Inventor: HAMILTON HAMISH WILLIAM
IPC: B25D9/04
Filed: 2010-03-23
Abstract: 594903 Disclosed is a device with an actuation system. The device has a dose chamber with an inlet for high pressure fluid, a working chamber extending away from the dose chamber and an annular wall separating a portion of the working chamber from the dose chamber such that the dose chamber encompasses the seperated portion of the working chamber. The annular wall is an annular valve member moveable between a sealed condition and an open condition. Fluid in the dose chamber flows from the dose chamber to the working chamber. In use an item to be driven along the working chamber is partially within the surrounded portion of the working chamber with the item at one end of its travel in the working chamber. The device also includes a valve mechanism to selectively allow high pressure fluid from the dose chamber to flow into the working chamber. The valve mechanism is operable to move the valve member to the unsealed condition.
Patent NZ-595585-A (NZ)
Title: Animal feed compositions and feeding methods
Inventor: GARDEN SCOTT
IPC: A23K20/195
Filed: 2010-04-21
Abstract: 595585 Discloses a method for increasing rumen ammonia production in a ruminant animal through the oral administration of rumen pH modulating amount of a hop acid; wherein the ruminant animal is administered an animal feed that is free from a polyether ionophore compound.
Patent NZ-596577-A (NZ)
Title: Sorting table featuring grading rolls with modifiable and adjustable gaps
Inventor: PELLENC ROGER
IPC: A23N15/02
Filed: 2011-11-22
Abstract: Disclosed is a sorting table with grading rolls arranged in parallel in succession of each other, so as to form a sorting plane. The grading rolls are supported by end supports. The sorting table includes means for the rotational drive of the grading rolls in the same direction. The rolls are arranged in a manner to create a number of openings between adjacent rolls so as to allow only the pass-through and the drop-off of the products to be sorted. Foreign objects or products of larger size than that of the products to be sorted will remain on the surface of the sorting plane and be evacuated at the downstream end. The sorting table includes means for modifying the gap between the rolls. The end supports of the grading rolls are mounted with a capability of limited translation on at least one lateral slide oriented perpendicularly to the axis of the rolls. Spring elements are interposed between the end supports and means of actuation act against the spring elements so as to allow the selective decrease or increase the cross section of the openings for pass-through of the sorted products. Displacement of the grading rolls is performed by the action of extension or compression of the elastic elements. The lateral slide is a lateral drive slide that constitutes the means of rotational drive of the rolls.
Patent NZ-598651-A (NZ)
Title: Edible surface-modifying particles and methods for their manufacture
Inventor: SOANE DAVID
IPC: A23L19/00
Filed: 2010-09-09
Abstract: Patent No. 598651 Disclosed is an edible surface-modifying particle precursor composition for preparing edible surface-modifying particles, comprising: a. a starch wherein about 85 to about 100% of said starch is amylopectin, wherein said amylopectin is about 25 to about 75% of the dry weight of the composition; and b. a grain meal wherein said grain meal is about 25 to about 75% of the dry weight of the composition.
Patent NZ-601256-A (NZ)
Title: Method and apparatus for stabilizing a mixing bucket
Inventor: SAUNDERS ROBERT MITCHELL
IPC: B65D1/14
Filed: 2010-08-03
Abstract: 601256 Disclosed is an apparatus and method for stabilising a mixing bucket (102). The bucket (102) has a cylindrical sidewall (104). A bucket interior volume is defined by separate lower and upper bucket rims. A laterally oriented bucket bottom spans the sidewall (104). The bucket bottom separates the bucket interior volume into an upper bucket volume and a lower bucket volume. The upper bucket volume is configured to contain the material being mixed. The sidewall (104) contains at least one aperture (120a, 120b). The aperture (120a, 120b) provides substantially laterally oriented access between an ambient environment and the lower bucket volume. At least one laterally oriented channel (122) extends from at least one aperture (120a, 120b) and is located within the lower bucket volume. An elongate anchoring structure (534) having first (536) and second (538) anchor ends is laterally separated by an anchor body (540). The removable anchoring structure (534) engages the bucket (102) by at least a portion of the anchor body (540) being positioned within the channel. An anchoring force is exerted by a user upon the anchoring structure (534) while engaged with the bucket (102) in the ambient environment. The anchoring force counteracts a mixing force being exerted upon the bucket (102) by the material being mixed thus stabilising the bucket (102).
Patent NZ-609568-A (NZ)
Title: Modified release pharmaceutical compositions of desvenlafaxine
Inventor: SAHOO ASHOK KUMAR
IPC: A61K31/137
Filed: 2012-04-11
Abstract: A modified release pharmaceutical composition comprising Desvenlafaxine Benzoate (O-desmethylvenlafaxine benzoate), one or more release modifying agent(s) and one or more pharmaceutically acceptable excipient(s), wherein Desvenlafaxine Benzoate is characterized by a powder X-ray diffraction pattern having peaks at about 5.4, 10.75, 16.6, 18.0, 19.2, 23.32 ± 0.2 degrees. Also disclosed are specific modified release pharmaceutical compositions wherein concentration and AUC of the modified release composition are independent of food effect.
Patent NZ-611541-A (NZ)
Title: Imidazo[4,5-c]quinolin-2-one compound and its use as pi3 kinase / mtor dual inhibitor
Inventor: BARDA DAVID ANTHONY
IPC: C07D471/04
Filed: 2012-01-11
Abstract: The disclosure relates to 8-[5-(1-hydroxy-1-methylethyl)pyridin-3-yl]-1-[(2S)-2-methoxypropyl]-3-methyl-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one, which is suitable for treating cancer selected from the group consisting of bladder cancer, colon cancer, gastric cancer, head and neck cancer, NSCLC, breast cancer, melanoma, ovarian cancer, pancreatic cancer, prostate cancer, glioblastoma, lung cancer, renal cancer, sarcoma, hematopoietic and lymphoid tissue cancer, CNS cancer, cervical cancer, endometrial cancer, liver cancer, skin cancer, stomach cancer, thyroid cancer, upper aerodigestive tract cancer, and urinary cancer.
Patent NZ-617503-A (NZ)
Title: System for treatment of lice, and corresponding method for treatment of lice
Inventor: ULRIKSEN ULRIK
IPC: A01K63/04
Filed: 2012-04-27
Abstract: A lice treatment system (and a method for a lice treatment) for fish comprises an inlet (1), a first separator (2), a pipeline (6), a second separator (7), an outlet (8) and a circulation pump (10). The inlet (1) receives the fish to be treated and the first separator (2) separates the fish from the water and the fish are then transported through the pipeline (6) including a liquid treatment bath (5) within the u-shaped part of the pipeline bordered by respective liquid surfaces (4). The second separator (7) separates the fish and the treatment liquid. The outlet (8) discharges the treated fish and is arranged after the second separator (7). The circulation pump (10) circulates the treatment liquid through the pipeline back from the second separator.
Patent NZ-619922-A (NZ)
Title: Metabolically engineered organisms for the production of added value bio-products
Inventor: MAERTENS JO
IPC: C12P19/30
Filed: 2011-07-12
Abstract: NZ 619922 Disclosed is the use of a 2-fucosyltransferase origination from Dictyostellium discoideum having an amino acid sequence given by SEQ ID NO 1, or, a fragment thereof having 2-fucosyltransferase activity, or, a variant thereof having a sequence identity of at least 75% and having 2-fucosyltransferase activity to produce fucosyllactose.
Patent NZ-622333-A (NZ)
Title: Headgear assembly for a respiratory mask assembly
Inventor: AMARASINGHE AMAL SHIRLEY
IPC: A62B18/08
Filed: 2003-09-05
Abstract: 622333 A headgear assembly is disclosed for maintaining a frame and cushion of a respiratory mask assembly in position on a patient user’s face. The assembly is constructed from a soft, flexible material and has two side portions and a rear portion between the side portions. Each side portion includes an upper side strap (22) to be located above the ear and eye of a user, and a lower side strap (24) to be located below the ear and eye of a user. The upper (22) and lower (24) side straps are connectable to a frame. The rear portion has a stiffening layer (46) which maintains the position of respective upper (22) and lower (24) side straps of the side portions spaced from the user’s ears.
Patent NZ-711771-A (NZ)
Title: Compositions for treating or preventing or reducing the severity of clostridium difficile related diseases
Inventor: MCKENZIE GREGORY
IPC: A01N65/00
Filed: 2014-02-04
Abstract: Disclosed herein are therapeutic compositions containing non-pathogenic, germination-competent bacterial spores, for the prevention, control, and treatment of gastrointestinal diseases, disorders and conditions and for general nutritional health.
Patent NZ-732149-A (NZ)
Title: Extended-release formulation for reducing the frequency of urination and method of use thereof
Inventor: DILL DAVID
IPC: A61K31/192
Filed: 2012-08-22
Abstract: Treating overactive bladder syndrome, using a dosage form comprising a immediate-release component and a extended-release component, each comprising acetaminophen and ibuprofen, each in an amount of 5 mg to 2000 mg in each component. The extended-release component may comprise an insoluble matrix, a polymer controlling release by dissolution controlled release, a water soluble or water-swellable matrix-forming polymer or a enteric coating.
Patent NZ-751156-A (NZ)
Title: Use of pridopidine for treating functional decline
Inventor: HAYDEN MICHAEL
IPC: A61K31/451
Filed: 2017-08-24
Abstract: This invention provides a method of maintaining functional capacity, improving functional capacity, or lessening the decline of functional capacity in a human patient with early stage Huntington’s disease comprising periodically orally administering to the patient a pharmaceutical composition comprising pridopidine such that a dose of 90-225 mg of pridopidine is administered to the patient per day, so as to thereby maintain functional capacity, improve functional capacity, or lessen the decline of functional capacity in the human patient.
Patent NZ-753075-A (NZ)
Title: Absorption, signaling and picking up of a potentially hazardous product
Inventor: BIGATA ERIC
IPC: B08B1/00
Filed: 2017-10-31
Abstract: The present invention covers a device for absorbing, signaling and picking up a product on a floor, said device comprising: - a slender hollow body whose inner walls define a storage volume in which is stored a powder able to absorb said product, where said storage volume opens through an opening for pouring said powder by gravity; - a stand on which one end of said body is mounted for forming a signaling marker, where said stand comprises a substantially flat base projecting radially relative to said body in order to place said device stably on the floor; wherein the base comprises at least two detachable parts which can be used for picking up a residue formed by said powder and said product.
Patent NZ-781101-A (NZ)
Title: Apparatus and method for spray drying
Inventor: ST PETER GLENN R
IPC: A23C1/04
Filed: 2016-11-03
Abstract: An electrostatic spray dryer for drying liquid into powder including an elongated body defining a drying chamber, a spray nozzle assembly at one end of the drying chamber and a filter element housing and powder collection chamber at an opposite end. A non-structural non-metallic liner is disposed within the elongated body in spaced relation to an inner wall surface for defining an internal drying zone. The liner is releasably supported within the body for enabling selective removal and replacement following a particular usage. The illustrated elongated body has a modular construction comprising a plurality of modules, with at least one being selectively removable and replacement for altering the length of the drying chamber for a particular spray application. The liner also is replaceable with a liner of a length corresponding to the altered length of the drying chamber or with a different diameter for a particular usage.
Patent NZ-790643-A (NZ)
Title: Topical montelukast formulations
Inventor: ROSENBERGER VERED
IPC: A61K31/47
Filed: 2021-02-02
Abstract: The present disclosure provides for topical emulsion comprising about 0.5% to about 10% Montelukast or pharmaceutically acceptable salt thereof; and about 0.4% to about 4% carbomer; wherein particles comprising the Montelukast in the emulsion have D90 of less than about 50 μm, wherein the Montelukast or pharmaceutically acceptable salt thereof is homogeneously dispersed in the emulsion, and wherein the emulsion has a pH of about 3.0 to about 6.5. The present disclosure also provides a topical gel comprising (a) about 0.5% to about 10% Montelukast or pharmaceutically acceptable salt thereof; (b) about 0.2% to about 8% cellulose polymer; and (c) about 80% to about 95% amphiphilic compound; wherein the gel comprises less than 4% water.